DOUGLAS EARL MARTIN (SVP, General Counsel) sold 5.7% of their position (29.70K shares) of ALLOGENE THERAPEUTICS, INC. on the open market
Open‑market sale worth $63.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/25/2026ACC: 0001628280-26-058920
Officer· SVP, General Counsel
Since Feb 2026
-29.70K
Net shares
Net seller
$63.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
29.70K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−29.70K
Price / share
$2.12
Trade value
$62.96K
% of position
5.7%
8/21/2026
517.96K→488.27K
Total
Net shares
−29.70K
Net value
-$62.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2026 | S · Sale | −29.70K | $2.12 | $62.96K | 5.7% | 517.96K | 488.27K |
| Total | −29.70K | -$62.96K | ||||||
Derivative Transactions0
No derivative transactions reported